AMERIPRISE FINANCIAL INC - MERRIMACK PHARMACEUTICALS IN ownership

MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 139 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q4 2015. The put-call ratio across all filers is 1.51 and the average weighting 0.1%.

Quarter-by-quarter ownership
AMERIPRISE FINANCIAL INC ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2016$69,000
+11.3%
10,818
-5.6%
0.00%
Q2 2016$62,000
-31.1%
11,458
+5.8%
0.00%
Q1 2016$90,000
-96.1%
10,833
-96.0%
0.00%
-100.0%
Q3 2015$2,309,000
-47.5%
271,409
-23.6%
0.00%
-66.7%
Q2 2015$4,395,000
+289.6%
355,425
+274.6%
0.00%
+200.0%
Q1 2015$1,128,000
-24.1%
94,880
-27.9%
0.00%0.0%
Q4 2014$1,487,000
+36.8%
131,569
+6.3%
0.00%0.0%
Q3 2014$1,087,000123,811
+412603.3%
0.00%
Q2 2014$0
-100.0%
30
-99.5%
0.00%
Q3 2013$23,000
-41.0%
6,143
+6.0%
0.00%
Q2 2013$39,0005,7940.00%
Other shareholders
MERRIMACK PHARMACEUTICALS IN shareholders Q4 2015
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 5,000,000$20,400,0004.19%
Consonance Capital Management LP 9,067,998$36,997,0004.06%
Lagoda Investment Management, L.P. 1,522,529$6,212,0002.13%
INDUS CAPITAL PARTNERS, LLC 1,050,000$4,284,0000.56%
WESTFIELD CAPITAL MANAGEMENT CO LP 9,072,877$37,017,0000.32%
GARRISON BRADFORD & ASSOCIATES INC 77,700$317,0000.29%
Cannell & Co. 1,572,978$6,418,0000.23%
Virtus ETF Advisers LLC 179,625$733,0000.22%
LeJeune Puetz Investment Counsel LLC 3,976$161,0000.12%
STONERIDGE INVESTMENT PARTNERS LLC 221,838$905,0000.12%
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders